BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 56 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | +382.0% | 14,258 | +20.2% | 0.00% | – |
| Q4 2019 | $50,000 | +11.1% | 11,866 | +0.8% | 0.00% | – |
| Q3 2019 | $45,000 | -2.2% | 11,766 | 0.0% | 0.00% | – |
| Q2 2019 | $46,000 | -9.8% | 11,766 | 0.0% | 0.00% | – |
| Q1 2019 | $51,000 | +24.4% | 11,766 | 0.0% | 0.00% | – |
| Q4 2018 | $41,000 | -6.8% | 11,766 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | -4.3% | 11,766 | 0.0% | 0.00% | – |
| Q2 2018 | $46,000 | +24.3% | 11,766 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -19.6% | 11,766 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | – | 11,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |